n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, December 4th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

UGE International Ltd. (UGEIF)

MarketWatch, OTC Markets Group, InvestorsHub, and Marketwired reported on UGE International Ltd. (UGEIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

UGE International Ltd. is a worldwide leader in distributed renewable energy solutions. The OTCQB-listed Company designs, manufactures, and sells renewable energy solutions. UGE provides solar solutions, wind turbines, and outdoor lighting services. The Company serves commercial and industrial clients in the U.S., Canada, Panama, the Philippines, and China. Formed in 2008, UGE International has offices in New York, New York; Toronto, Ontario; and Mabolo, Cebu City, Philippines.

UGE International helps commercial and industrial clients in becoming more competitive via the low cost of distributed renewable energy. The Company has developed its proprietary site assessment and planning platform. This has allowed UGE to deploy solutions in greater than 80 nations. UGE International has more than 340 MW of experience internationally.

UGE International also provides remote site design, installation, monitoring, site assessment, engineering, procurement, construction, and financing services. The Company’s site assessment includes load analysis to energy forecasting. Its engineering includes system design to as-built drawings. UGE delivers immediate savings to businesses through cleaner electricity.

UGE International purchased largely all the assets of Carmanah Solar Power Corp. (CSPC), by way of a majority-owned joint venture (JV) with affiliates of OYA Solar, Inc. and Polar Racking, Inc. CSPC is a wholly-owned subsidiary of Carmanah Technologies, Inc. (CMH).

CSPC is one of the longest tenured and most experienced solar businesses in Canada. Together, UGE International and CSPC combine leading market shares in rooftop and ground-mount projects to further strengthen UGE's position in the U.S. and Canada.

Last month, UGE International announced it signed a new contract to design, construct, and commission a 300 kW DC solar PV carport system for Royal Oak Audi, which is an Audi dealership in Calgary, Alberta. UGE is partnering on the project with local solar company Sol Power Projects Ltd.

It is tapping into their local experience and knowledge of market dynamics to maximize customer outreach, minimize installation costs, and leverage the Alberta government’s solar rebate. The solar carport project will provide coverage for 112 Audi vehicles while offsetting 267 tons of carbon each year, the equivalent of driving greater than 590,000 miles by an average passenger vehicle.

In addition, in November, UGE International announced it secured three new contracts to deploy commercial solar projects in the greater Boston, Massachusetts area. The Company will deploy rooftop solar installations at each of the three buildings.

Taking advantage of ever-improving solar economics, the projects will help the buildings’ owners to save money on their monthly energy bills. This is while providing free roof upgrades as part of the project's economics.

UGE International Ltd. (UGEIF), closed Monday's trading session at $0.27, even for the day, on 10,000 volume with 1 trade. The average volume for the last 60 days is 12,172 and the stock's 52-week low/high is $0.2165/$0.563.

Emerald Medical Applications Corp. (MRLA)

OTC Markets, MarketWatch, and YCharts reported on Emerald Medical Applications Corp. (MRLA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Emerald Medical Applications Corp. is a medical technology company based in Petach Tikva, Israel. It utilizes proprietary military image processing technology and state-of-the-art data analytics to improve the analysis of medical images. The Company engages in the development and sale of DermaCompare™. This is its proprietary Artificial Intelligence (AI) technology and application for the early diagnosis of melanoma and other skin cancers. Emerald Medical Applications lists on the OTC Markets’ OTCQB.

Emerald Medical Applications was awarded the Grand Prize of 500,000 Euros over 3,500 other competing technology companies at Publicis Groupe's "Publicis 90" Initiative at the Viva Technology event held in Paris, France in early July of 2016.

DermaCompare is the first application of the Company’s technology and innovation. Its technology uses the knowledge of military image processing and big data analytics to improve the analysis of medical images for the benefit of patients and the medical community. DermaCompare is a Food and Drug Administration (FDA) Class #1 approved, HIPPA-compliant, skin cancer (melanoma) screening platform.

DermaCompare enables patients to self-conduct a dermatology scan utilizing Total Body Photography Imaging (TBP) taken with a digital camera, typically a tablet or Smartphone (iPhone or Android). The application (App) and instructions can be downloaded on almost any device with a digital camera.

DermaCompare provides actionable pieces of information, higher quality with reduced costs. It is aligned with population health management initiatives taken by governments around the world.

DermaCompare enables home use by using every Smartphone. It applies AI and predictive analytics, and maps the ‘Melanoma Starting Point’. DermaCompare is a pioneering skin cancer screening platform. It enables physicians to identify and monitor changes in their patients’ skin characteristics.

Upon a patient uploading their TBP images to their file in the DermaCompare cloud for storage and review, the DermaCompare platform compares those images to any prior patient images on file, as well as any relevant images from Emerald’s database. The DermaCompare platform also updates the patient file and creates a summary of data points with current, relevant data pertaining to the patient's skin images together with alerts to any suspicious image changes.

In addition, the DermaCompare platform notifies the associated physician to retrieve and review the patient's chart and TPB images. DermaCompare integrates augmented reality. This allows physicians to review the patient’s skin, using their smartphone or Google Glass.

The platform will provide for the first time a global multi-dimensional database of the human skin accessible anytime, anywhere. The Company’s technology originated from the concepts applied by the Israeli Air Force and the intelligence services that employ auto aerial photo diagnostics to track collateral damage after engaging the enemy.

Emerald Medical Applications Corp. (MRLA), closed Monday's trading session at $0.022, down 0.90%, on 30,000 volume with 3 trades. The average volume for the last 60 days is 24,082 and the stock's 52-week low/high is $0.0125/$0.51.

Equitorial Exploration Corp. (EQTXF)

MarketWatch, Stockhouse, 4-Traders, and Investing News reported on Equitorial Exploration Corp. (EQTXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A junior resource enterprise, Equitorial Exploration Corp. focuses on lithium. The Company is developing three significant, 100 percent-owned, high-potential, lithium projects in North America. One is the Little Nahanni Pegmatite Group Property (LNPG) in the Northwest Territories (NWT). The second is the Tule Valley Lithium Brine Project in Utah. The third is the Gerlach Lithium Brine Project in Nevada.

Equitorial Exploration is headquartered in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Little Nahanni Pegmatite Property is in the NWT, adjacent to the Yukon border. This prospect consists of 5,393 ha (53.93 km2). Minerals of interest are spodumene, lithium micas, tantalite-columbite and cassiterite. Equitorial Exploration optioned the claims in 2016. The Company started exploration with a carefully executed channel sampling program, which Archer Cathro and Associates (1981) Limited performed.

The Tule Valley Project comprises 26 claims of 26 acres each. It is positioned southwest of Salt Lake City, Utah. The terrain is readily amenable to the construction of the required infrastructure related to mining operations. This includes, but is not limited to, potential tailings storage sites, potential waste disposal areas, heap leach pad areas, and potential processing plant sites.

The Tule property is 20 km south of Redhill Resources Honey Comb-Beryllium-Rubidium, Lithium and REE project. Tule is roughly 60 km to the northwest of the Crystal Peak potash, lithium and magnesium project. It is also 30 km to the southwest of Matererion’s Spor Mountain Beryllium Mine.

The Gerlach Lithium Brine Project consists of 89 claims, 720 hectares (1,780 acres), situated in the San Emidio desert, 5 miles from Gerlach, Wahoe County, Nevada and 120 km north of Tesla Gigafactory #1. This property is within the southern lobe of the Black Rock Desert. The expectation is that Gerlach exploration will concentrate at first on geophysical surveying, specifically IP, to detect conductive layers beneath the playa floor.

Equitorial Exploration also has a 50/50 Joint Venture with Mag One Products, Inc. It has first right to finance equally the construction of Mag One’s first magnesium and refining production facility to produce magnesium metal and related products.

Equitorial Exploration Corp. (EQTXF), closed Monday's trading session at $0.1086, even for the day. The average volume for the last 60 days is 20,567 and the stock's 52-week low/high is $0.027/$0.1145.

Manhattan Scientifics, Inc. (MHTX)

StockHotTips, Hawk Associates, The Penny Play, BullRally, SmallCapVoice, OurHotStockPicks, AllPennyStocks, Xtremepicks, FeedBlitz, and HotStockChat reported earlier on Manhattan Scientifics, Inc. (MHTX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Manhattan Scientifics, Inc. concentrates on the commercialization of disruptive technologies in the nano-medicine space. Currently, the Company is developing commercial medical prosthetics applications for its ultra-fine grain metals. Its objective is to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, (now Imagion Biosystems) its wholly-owned subsidiary. Manhattan Scientifics has its corporate office in New York, New York and an office in Albuquerque, New Mexico, and Montreal, Quebec.

Manhattan Scientifics centers on technology transfer and commercialization of transformative technologies in the nano medicine space. It creates Intellectual Property (IP) portfolios and business cases supporting new technologies

The Company guides them to relationships with industrial partners who are well-prepared to launch product. Consequently, the lab and inventor see the technology enter the market. The industrial partner gets a strong foundation for a new product. Manhattan Scientifics profits from building the licensing bridge to industry.

Manhattan Scientifics has expertise in licensing from the national laboratories (the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL)) and in working with individual inventors.

The Company’s technology uses iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods. Senior Scientific has established a research collaboration with Weill Cornell Medicine. For this alliance, it will bring its magnetic relaxometry technology to Weill Cornell Medicine. Scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers.

Manhattan Scientifics has an agreement to collaborate with The University of Texas M.D. Anderson Cancer Center (MDACC) to advance, demonstrate, and validate a pioneering technology developed by Mr. Edward R. Flynn, PhD, for the very early detection of cancer. Manhattan Scientifics has delivered its unique cancer measurement instrument to MDACC.

The Company is now concentrating on nanoparticle based cancer detection via Senior Scientific. Furthermore, it is focusing on nanostructured metals technology by way of wholly-owned subsidiary Metallicum, Inc.

Manhattan Scientifics is also working on the start of product trials on its cancer detection product. The nanostructured metals technology has been revenue producing for some years. The cancer detection technology can detect cancer years earlier.

Manhattan Scientifics, Inc. (MHTX), closed Monday's trading session at $0.025, up 8.70%, on 224,975 volume with 10 trades. The average volume for the last 60 days is 133,151 and the stock's 52-week low/high is $0.018/$0.051.

OptimizeRx Corp. (OPRX)

Streetwise Reports, Marketbeat.com, and Bull in Advantage reported on OptimizeRx Corp. (OPRX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OptimizeRx Corp. provides inventive consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. The Company does so while providing pharmaceutical and healthcare companies effective ways to expand awareness, access, and adherence to their medications. OptimizeRx is the foremost aggregator of pharmaceutical-sponsored services in electronic health record (EHR) platforms. The Company’s core product is SampleMD. A health technology software company, OptimizeRx has its headquarters in Rochester, Michigan.

The Company first launched its SampleMD e-coupon solution in April 2015 within Practice Fusion's EMR. It promotes patients’ savings and support from the world's largest pharmaceutical companies. These include Pfizer, Lilly, Novartis, AstraZeneca, and many others.

OptimizeRx’s SampleMD replaces drug samples with electronic trial vouchers and co-pay coupon savings. These are electronically added to an e-Prescription and sent electronically to the pharmacy and are integrated within top Electronic Health Record (EHR) platforms in the nation. These include Allscripts, DrFirst, NewCrop, Quest Diagnostics, and Practice Fusion, and other EHRs.

In addition, OptimizeRx launched its OPTIMZEHR™. This is its consulting and implementation practice to assist pharmaceutical-biotechnology companies and healthcare provider platforms in determining and executing on mutually beneficial opportunities to jointly assist physicians and patients within their EHR workflow.

OptimizeRx has a group of services that integrate complete brand support into the EHR. This leads to enhanced patient care and improved outcomes. The offerings include Brand Messaging and Brand Support. OptimizeRx’s core product has been financial messaging, providing physicians with electronic coupons, co-pay offers, and vouchers for their patients at the point of care (PoC).

Last month, OptimizeRx reported results for Q3 ended September 30, 2017. Net revenue rose 74 percent to a record $3.1 million. This was driven by growth in financial and brand messaging by new and returning clients. Financial messages, such as eCoupons, and brand messaging were distributed for over 100 pharmaceutical brands during Q3.

Net loss for Q3 of 2017 was $623,000 or $(0.02) per share, versus a net loss of $243,000 or $(0.01) per share in Q3 of 2016.

OptimizeRx has directly integrated its financing messaging with Amazing Charts, a foremost EHR and subsidiary of Harris Healthcare, to help patients save money and be better educated about prescriptions. OptimizeRx services will operate seamlessly within the Amazing Charts EHR workflow and alert health care providers (HCPs) to prescription savings and support information for patients. The integration is now in beta. It is planned for general release by the end of this month.

Amazing Charts provides EHR, practice management, and other Health IT solutions. These have been adopted by over 11,000 clinicians in more than 7,500 private practices.

OptimizeRx Corp. (OPRX), closed Monday's trading session at $1.58, up 1.28%, on 8,737 volume with 11 trades. The average volume for the last 60 days is 24,762 and the stock's 52-week low/high is $0.63/$1.60.

Value Exchange International, Inc. (VEII)

Nebula Stocks and Real Pennies reported earlier on Value Exchange International, Inc. (VEII), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Value Exchange International, Inc. is a provider of Mobile Payment Gateway (QR code purchase at POS (Point-of-Sale)) customer-centric solutions for the retail industry in Asia. It provides credit and debit card processing services to multinational retailers in Asia. The Company formerly went by the name Sino Payments, Inc. It changed its name to Value Exchange International, Inc. in October of 2016.

Value Exchange International is based in Hong Kong SAR. The Company also has offices in Shenzhen, Guangzhou, Shanghai, and Beijing in China, and in Manila and Kuala Lumpur. Value Exchange International lists on the OTCQB.

The Company integrates market-leading Point-of-Sale/Point-of-Interaction (POS/POI), Merchandising, CRM & Reward, Locational Based (GPS & Indoor Positioning System (IPS)) Marketing, Customer Analytics, and Business Intelligence solutions. Its retail solutions process tens of millions of transactions each year through approximately 20,000 retail outlets in Asia serviced by the Company.

Value Exchange International provides POS systems installation, maintenance, software, and systems support and solutions as required to its retail outlets in the Hong Kong SAR-Macau-China region.

The Company’s intention is to provide Internet protocol processing services to bank card-accepting merchants. Furthermore, it provides systems maintenance and related services; and systems development and integration services.

Value Exchange International is supporting TapServices, Inc. (a Philippine company) in providing subcontracting support and maintenance services to NCR Singapore for NCR Singapore’s implementation of POS support and maintenance services for up to 120 supermarket stores in Singapore. The implementation is taking place with setup work scheduled for completion in 2017.

The service arrangement represents Value Exchange International’s first project in Singapore. Value Exchange International provides information technology (IT) and POS services and operations management to TapServices as a subcontractor. Value Exchange International acquired 100 percent of the issued and outstanding stock of TapServices under a January 23, 2017 Stock Purchase Agreement.

This past October, Value Exchange International announced the beginning of implementation of customer self-checkout systems in China, Hong Kong, and Malaysia for the largest Chinese health care and beauty retailer.

Mr. Kenneth Tan, Chief Executive Officer of Value Exchange International, said, “We are delighted to provide the first large scale rollout of customer self-checkout systems in China, Hong Kong and Malaysia for the largest health care and beauty care retail chain in China. This is an important step in our strategy to expand our operations in Malaysia and South East Asia. The initial rollout includes customer self-checkout systems for projected 3,000 stores in China and 300 stores in Hong Kong.”

Value Exchange International, Inc. (VEII), closed Monday's trading session at $0.065, even for the day. The average volume for the last 60 days is 11,004 and the stock's 52-week low/high is $0.033/$0.17.

Cartesian, Inc. (CRTN)

Stock Twits, InvestorsHub, The Street, and StockNewsUnion reported on Cartesian, Inc. (CRTN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cartesian, Inc. is a foremost provider of consulting services and managed solutions to the worldwide telecommunications, media, and technology industries. The Company provides strategic advice, management consulting, as well as managed solutions to clients around the world. Cartesian lists on the OTC Markets Group’s OTCQB. The Company has offices in Boston, Kansas City, New York, Philadelphia, and London.

Cartesian’s clients include Service Providers and Network Operators; Technology Firms; and Digital Media Producers and Distributors. Clients additionally include Government and Regulatory Authorities; Industry Associations, and Private Equity Firms.

With its technical and commercial know-how, the Company assists its clients across their core business operations. Cartesian helps with customer acquisition and retention; network transformation, business strategy and planning, product management, and investment advisory. It also helps with business operations and change, assurance and cost optimization, video services delivery and security, and regulatory support and expert witnesses.

Recently, Cartesian announced that Mr. Donald J. Tringali was appointed as Executive Chairman of the Company’s Board of Directors. Mr. Tringali will perform all duties normally performed by a Board Chairman. He has served as a director of Cartesian since April 2016.

Mr. Tringali will lead the Board's efforts in working closely with management to formulate and implement strategic and operational initiatives to enhance Cartesian’s performance. Mr. Peter Woodward remains Chief Executive Officer (CEO). Former Chairman Mr. Robert Currey will continue as a member of the Board of Directors.

Last month, Cartesian reported financial results for Q3 ended September 30, 2017. The Company’s revenue declined by 26 percent to $12.8 million; this is from $17.3 million in the same prior year period. This decrease was chiefly because of lower volumes of projects in North America and EMEA versus the year-ago quarter.

Gross margin was 32 percent in Q3 2017 versus 35 percent in Q3 2016, mainly because of project mix. Gross profit decreased 33 percent to $4.1 million in Q3 2017 versus $6.1 million in Q3 2016. The decrease in gross profit was mainly because of unfavorable project mix in North America.

GAAP net loss for Q3 2017 was $1.3 million, or $0.15 per diluted share. GAAP net income for Q3 2016 was break-even.

Cartesian, Inc. (CRTN), closed Monday's trading session at $0.2555, down 1.77%, on 29,104 volume with 36 trades. The average volume for the last 60 days is 59,230 and the stock's 52-week low/high is $0.2106/$1.57.

graphic

The QualityStocks
Company Corner

graphic
graphic

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $1.09, up 9.37%, on 256,828 volume with 242 trades. The stock’s average daily volume over the past 60 days is 99,102, and its 52-week low/high is $0.3148/$1.3041.

First Cobalt Corp. (TSX-V:FCC) (ASX:FCC) (OTCQB:FTSSF) is pleased to report high grade cobalt assays at the past producing Juno mine in Cobalt North, to the north of the Drummond mine. Surface sample results from the Juno mine in the Kerr Lake area suggest that a broad hydrothermal system may exist in the area. Also today, Uptick Newswire interviewed FTSSF’s President and CEO, Trent Mell, on the Company’s major successes and the big plays First Cobalt has made in the cobalt industry. Starting off the interview, Mr. Mell discusses the difference of First Cobalt, the importance of the team and the field commodities that are significant to First Cobalt’s land profitability.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

First Cobalt Reports 3.9% Cobalt in Kerr Lake Area

Uptick Newswire “Stock Day” Interviews CEO on First Cobalt’s 2017 Success in the Cobalt Industry

First Cobalt Commences Borehole Geophysics at Keeley-Frontier

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (FTSSF). Today, Petroteq Energy Inc. closed trading at $1.8296, up 4.12%, on 203,824 volume with 361 trades. The stock’s average daily volume over the past 60 days is 69,509, and its 52-week low/high is $0.015/$1.8665.

PetroBLOQ today announces that it has become the latest member to join the Enterprise Ethereum Alliance (EEA), the world's largest open-source blockchain initiative. PetroBLOQ's novel blockchain-based oil and gas supply chain management platform is being co-developed by Petroteq Energy, Inc. (TSXV: PQE) (OTCQX: PQEFF) (FSE: MW4A) and First Bitcoin Capital Corp.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy Announces Petrobloq's Membership in Enterprise Ethereum Alliance

OPEC extension promises faster payback period for Petroteq's Asphalt Ridge Plant

Petroteq Energy, Inc., Pioneering Technologies in the Energy Industry

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $0.7669, up 3.26%, on 80,031 volume with 38 trades. The stock’s average daily volume over the past 60 days is 123,198 and its 52-week low/high is $0.248/$2.119.

MGX Minerals Inc. (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to report that joint venture partner Power Metals Corp. (“Power Metals”) has announced assay results confirming the presence of high-grade spodumene in the Northeast dyke at Case Lake, Cochrane, Ontario. Power Metals reports that the assay results range from 6.04% to 7.14% Li2O for spodumene rock samples on surface. The assays given in Table 1 represent almost pure spodumene and drilling is required to determine the lithium grade of the Northeast pegmatite dyke. Power Metals has planned a 2,000 metre drill program that will commence on the Northeast dyke in early January 2018.

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals’ Joint Venture Partner Power Metals Samples up to 7.14% Li2O on Surface at Case Lake Lithium Property

MGX Minerals Engages Senator Richard Polanco (Ret.) to Direct California Lithium Brine Strategy

MGX Minerals to Open Office in Santiago, Chile to Evaluate New Projects and Joint Ventures

Veritas Pharma, Inc. (CSE:VRT) (OTC:VRTHF) (FRT:2VP)

The QualityStocks Daily Newsletter would like to spotlight Veritas Pharma, Inc. (VRTHF). Today, Veritas Pharma, Inc. closed trading at $0.7277, up 2.33%, on 325,897 volume with 219 trades. The stock’s average daily volume over the past 60 days is 91,855 and its 52-week low/high is $0.171/$0.7401.

NetworkNewsWire, a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (FRT:2VP), an emerging-stage pharmaceutical and IP development company that, through its 80% owned Cannevert Therapeutics Ltd. ("CTL") subsidiary, seeks to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims. The publication, titled, “Investors Could Reap Global Rewards of Research into Medical Cannabis Science,” highlights focused and increased efforts in the research and development of the use of cannabis for a variety of medicinal purposes. To view the full publication, visit: https://www.networknewswire.com/investors-reap-global-rewards-research-medical-cannabis-science/

Veritas Pharma, Inc. (CSE: VRT) (OTCQB: VRTHF) is an emerging pharmaceutical and IP development company publicly traded in Canada, the United States and Germany. Through its recently acquired 80 percent stake in Cannevert Therapeutics Ltd., also known as Veritas' R&D arm, the company is clinically profiling various marijuana cultivars to pharmacologically connect unique strains with specific disease conditions. Veritas Pharma's goal is to perform clinical trials to prove the efficacy of the designated lead cannabis strains and to market the clinically effective cultivars as prescription medicines in a fast-track protocol.

Veritas Pharma's management and R&D team comprises decades of pharmaceutical, clinical and scientific research expertise into several key industry leaders. Lui Franciosi, PhD, who has over 20 years of experience conducting pharmaceutical and medical device studies in academia and industry, leads the company as its CEO. In addition to a team of trained technicians and students working out of academic facilities, Veritas Pharma is pleased to have a renowned group of scientists on board to lead its research efforts. Team members hold 10 PhDs/MD licenses with expertise in chemistry, pharmacology and clinical trials.

Veritas Pharma's mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company's approach, combined with its strategic alliances, will effectively address the medical community's concerns over the complexities of cannabis potency, efficacy, quality and content in the nearly 800 marijuana strains currently known in the world. Opportunities for innovation and scientific advancement related to the field of cannabis therapeutics will accelerate the knowledge base and provide a valuable alternative to the global opioid market that is estimated at nearly U.S. $35 billion. A growing negative opinion regarding the use of opioids for pain will continue to drive the need for alternative medical applications such as those provided by cannabis.

Veritas Pharma's clinical cannabis development pipeline includes R&D for chronic pain, nausea, inflammation, muscle spasms, epilepsy and Post Traumatic Stress Disorder. The strategic alliance formed with Cannevert and its scientists will enable Veritas to be at the forefront of developing new and unique strains of medicinal cannabis. These plants, which they plan to patent protect for a variety of unmet medical needs, are destined to help patients suffering with chronic and debilitating symptoms of a variety of medical issues. Over 250 experiments have been performed so far with another 150 pharmacological and biological studies conducted. Veritas Pharma has also entered into an agreement with Sechelt Organic Marijuana Inc., which has a Licensed Producer application pending with Health Canada, to acquire 100 percent ownership in the company.

Results of the company's research to date illustrate Veritas' unique place in the medical marijuana industry. The company's focus on the biological effect of the actual spectrum of cannabinoids sets Veritas apart as it seeks to patent and protect results-driven strains. Disclaimer

Veritas Pharma, Inc. Blog

Veritas Pharma, Inc. News:

NetworkNewsWire Announces Publication on Investment Opportunities Created by Ongoing R&D of Medical Cannabis

Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board

US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert

Carl Data Solutions Inc. (CSE: CRL) (FSE: 7C5) (OTC: CDTAF)

The QualityStocks Daily Newsletter would like to spotlight Carl Data Solutions Inc. (CDTAF). Today, Carl Data Solutions Inc. closed trading at $0.3584, off by 8.80%, on 102,841 volume with 48 trades. The stock’s average daily volume over the past 60 days is 1,450 and its 52-week low/high is $0.2015/$0.3984.

Carl Data Solutions Inc. (CSE:CRL, FSE:7C5, OTC:CDTAF), is pleased to announce that, further to its press releases dated January 17, 2017, March 9, 2017 and October 20, 2017, it has completed the acquisition (the "Acquisition") of certain intellectual property assets, tangible assets, and intangible assets from AB Embedded Systems Ltd. ("AB Embedded") pursuant to the asset purchase agreement dated November 30, 2017 between Carl and AB Embedded.

Carl Data Solutions Inc. (CSE: CRL) (FSE: 7C5) (OTC: CDTAF), a developer of Big-Data-as-a-Service ("BDaaS")-based solutions for data integration, business intelligence and Industrial Internet-of-Things ("IIoT") applications, is headquartered in Vancouver, British Columbia, Canada. The company's BDaaS enterprise applications platform provides custom cloud-based collection, storage, monitoring and advanced analysis of any data source of any size or complexity.

Carl Data Solutions provides smart, real-time solutions for industries that routinely face an overload of data. The company's team of dedicated data scientists and application developers build environmental monitoring and modeling technology that collects, connects and manages data to protect industrial and infrastructure assets. As experts in data collection, storage, analytics and reporting, the team is experienced in the complex issues facing governmental and industrial sectors and is well positioned in key IIoT market segments to offer customized solutions.

Among the benefits of CARL's Big Data solutions: turning vast quantities of information into meaningful, actionable insights for any business; gathering data from multiple sources and monitoring in real-time, allowing for better decision making and forecasting; identifying business performance issues or operational efficiencies quickly and accurately for cost and time savings; and, mitigating risks with predictive analytic capabilities to manage unplanned events.

The company's most recent acquisitions include:

  • FlowWorks, a SaaS-based monitoring, data collection, alarming, modeling and reporting system utilized by major clients across North America.
  • abEmbedded Systems Ltd., a Mesh and LoRa advanced telemetry platform using industrial grade custom sensors and data loggers operating in over 250 pump stations across North America.
  • Extend to Social (ETS), a social media application that adds a deep analytics layer that provides clients with valuable insights for new marketing campaigns plus behavioral characteristics for customer service, operations and product development.

Carl Data Solutions provides scalable solutions that integrate public data, Smart IIoT and legacy devices that provides real-time alarming and data analysis. Development of a framework that manages large volumes of diverse types of both structured and unstructured data, stored in an unlimited cloud-based platform that offers advanced analytics features for deeper data insights, provides instant analysis of any inbound data. CARL's applications locate relationships and patterns, which can then predict the probability of specific events, providing valuable insights applicable to any entity dealing with operational issues and regulatory requirements. Both technical and business users are able to quickly and easily understand the impact of environmental events on infrastructure through a comprehensive suite of dashboards, geographic information systems and graphic tools.

The company's predictive analytics, machine learning, and web-based applications can be utilized for waste and storm water management, in the protection of oil and gas pipeline stream crossings, and by hydro-electric dams and toxic tailing ponds, among other industrial uses. The global industrial IoT market alone is expected to reach USD $933.62 billion by 2025, according to a new report by Grand View Research, Inc. (http://nnw.fm/yLBv0). Businesses are seeking new operating models that will increase overall productivity, enhance operational efficiency, improve visibility and reduce complexities of various processes – all of which are targets of Carl's Data Solutions.

An expert management team is at the company core with Greg Johnston leading as its president, CEO and director. Johnston is an experienced technology professional with a proven track record of leadership success within both large multinational corporations and small start-up technology ventures. Disclaimer

Carl Data Solutions Inc. Blog

Carl Data Solutions Inc. News:

Carl Data Solutions Completes Acquisition of Assets of AB Embedded Systems

Carl Data Solutions Announces Closing of Private Placement

Carl Data Solutions Announces Rights Offering

Zinc One Resources, Inc. (TSX-V: Z) (OTC: ZZZOF) (FSE: RH33)

The QualityStocks Daily Newsletter would like to spotlight Zinc One Resources, Inc. (ZZZOF). Today, Zinc One Resources, Inc. closed trading at $0.3011, up 22.60%, on 32,600 volume with 20 trades. The stock’s average daily volume over the past 60 days is 51,471 and its 52-week low/high is $0.011/$0.81.

Zinc One Resources, Inc. (TSX-V: Z) (OTC: ZZZOF) (FSE: RH33) is a Vancouver, Canada-based company focused on the acquisition, exploration and development of prospective and advanced zinc projects in mining friendly jurisdictions. Zinc One's key assets are the Bongará Zinc Mine and Charlotte-Bongará Zinc-Oxide Project in north-central Peru. Historical production of the Bongará Mine, which was mined from 2007-2008 until a fall in zinc prices shut it down, revealed greater than 20 percent zinc grades and recoveries over 90 percent, all from surface mining. Bongará's high grade zinc mineralization is considered a rare situation and one that Zinc One management is poised to explore further. The neighboring Charlotte-Bongará Zinc-Oxide Project has multiple at-surface, high-grade drill intercepts providing numerous drill targets.

Zinc One controls both zinc-oxide mine projects, making it the first time a single operator has been in control of the two locations, giving the company a unique opportunity to delineate a substantial high-grade, zinc-oxide resource along a 4 kilometres-long trend. A previous operator produced 55.1 million pounds of zinc, running at 358 tonnes a day. Zinc One has access to all data and technical work dating back to the 1990s and controls a third zinc prospect located in central Peru as part of its portfolio.

The company has also received approval from Peru's Ministry of Energy and Mines to suspend the mine closure at the Bongará location, which allows Zinc One to utilize the current Environmental Impact Assessment attached to the project for current and future permitting. This critical approval allows the company to take another important step forward in its plans to reopen production at the Bongará zinc-oxide project. Zinc One's project locations involve open pit/surface mining, requiring less infrastructure and a much better cost ratio than traditional underground mines.

Zinc One is managed by a proven team of exploration geologists and engineers with extensive experience in constructing and operating successful mining operations. The company's business strategy includes restarting production at the Bongará Zinc-Oxide Mine with exploration of targets along a 6-kilometer strike as well as exploring the Charlotte Bongará Zinc-Oxide Project.

World stockpiles of zinc are at multiyear lows while demand continues to be strong. In 2016, zinc demand became greater than the available supply for the first time in a decade. Zinc is essential for rustproofing steel and is used in a variety of infrastructures. It's also used to produce batteries, fertilizers, paints, plastics, cosmetics and multivitamins. The International Zinc Association estimates that zinc could save the world over $300 billion annually in direct corrosion costs and another $300 billion annually in indirect costs. Zinc is an invaluable base metal and a strategic priority for many industries. Disclaimer

Zinc One Resources, Inc. Blog

Zinc One Resources, Inc. News:

NetworkNewsWire Announces Publication Detailing Strong Demand in Global Zinc Market

NetworkNewsWire Announces Publication Highlighting Growing Global Zinc Deficit Amid Rising Demand

NetworkNewsWire Announces Publication Discussing Several Stocks Gearing Up to Fill Zinc Shortage

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.1235, up 17.53%, on 28,479,243 volume with 2,117 trades. The stock’s average daily volume over the past 60 days is 7,282,197, and its 52-week low/high is $0.01/$0.415.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

CannabisNewsWire Announces Publication Discussing Payment Processing Solutions for the Cannabis Marketplace

AppSwarm and SinglePoint Finalize Plans for Cannabis and Bitcoin Focused Applications and Technology

CannabisNewsWire Announces Publication on the Price of Bitcoin and Several Investment Options in Cryptocurrency

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketBeat
(ANFC) +172.22%

2.

PoliticsAndMyPortfolio
(DPW) +90.71%

3.

Penny Picks
(INND) +77.87%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251